Therapeutic siRNAs

Trends Pharmacol Sci. 2004 Jan;25(1):22-8. doi: 10.1016/j.tips.2003.11.006.

Abstract

The ability of small-interfering RNAs (siRNAs) to silence gene expression in somatic mammalian cells has provided researchers with a novel tool to block the expression of disease-causing genes, provided that their mRNA sequences are known. siRNAs can be delivered to cells either exogenously as synthetic agents or endogenously as gene-encoding siRNAs. Recent studies demonstrate the general application of siRNAs to silence gene expression in a range of cell types and in whole mammals. Beyond their value for dissecting gene functions and target validation, siRNAs also hold great potential as gene-specific therapeutic agents.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cells, Cultured
  • Disease Models, Animal
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Molecular Biology
  • RNA, Small Interfering / administration & dosage
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / therapeutic use*
  • Virus Diseases / genetics
  • Virus Diseases / therapy*

Substances

  • RNA, Small Interfering